Lactose-Free Infant Formula Market

By Product;

Organic and Conventional

By Distribution Channel;

Supermarkets & Hypermarkets, Convenience Stores and Online

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn022160680 Published Date: September, 2025 Updated Date: October, 2025

Lactose-Free Infant Formula Market Overview

Lactose-Free Infant Formula Market (USD Million)

Lactose-Free Infant Formula Market was valued at USD 20,209.23 million in the year 2024. The size of this market is expected to increase to USD 42,356.10 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 11.2%.


Lactose-Free Infant Formula Market

*Market size in USD million

CAGR 11.2 %


Study Period2025 - 2031
Base Year2024
CAGR (%)11.2 %
Market Size (2024)USD 20,209.23 Million
Market Size (2031)USD 42,356.10 Million
Market ConcentrationLow
Report Pages365
20,209.23
2024
42,356.10
2031

Major Players

  • Nestlé S.A.
  • Danone S.A.
  • Abbott Laboratories
  • Mead Johnson Nutrition Company
  • Perrigo Company plc
  • HiPP GmbH & Co. Vertrieb KG
  • Beingmate Baby & Child Food Co., Ltd.
  • Ausnutria Dairy Corporation Ltd.
  • Hain Celestial Group, Inc.
  • Reckitt Benckiser Group plc

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Lactose-Free Infant Formula Market

Fragmented - Highly competitive market without dominant players


The Lactose-Free Infant Formula Market is expanding rapidly as parents prioritize specialized nutrition for infants with lactose intolerance. Nearly 50% of families with affected children choose lactose-free formulas to support easier digestion and overall comfort. This shift toward tailored infant care is fueling consistent market growth.

Health-Centric Nutrition Trends
The rising focus on digestive health is strengthening demand for lactose-free formula as a trusted solution. About 46% of caregivers consider these products essential for nutrient absorption and infant well-being. The growing recognition of balanced nutrition during early life is further accelerating market adoption.

Influence of Pediatric Recommendations
Clinical support is becoming a major driver, with around 42% of pediatric visits resulting in advice to use lactose-free formulas. These recommendations highlight the increasing role of medical guidance in parental purchasing decisions. The emphasis on safe infant feeding reinforces the market’s importance.

Innovation in Infant Formula Development
Continuous advancements in formula design are shaping consumer preferences. Close to 38% of new introductions focus on nutritional enhancements and improved digestibility. Additives like prebiotics and unique protein blends are elevating the appeal of these formulas, catering to evolving parental expectations.

Future Growth Outlook
The lactose-free infant formula market is positioned for sustained growth, supported by health-conscious demand, medical endorsements, and innovative product pipelines. Over 44% of parents express readiness to invest more in specialized infant nutrition, indicating robust potential. Increasing awareness and research-driven product advancements will continue shaping the market’s expansion.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Distribution Channel
    3. Market Snapshot, By Region
  4. Lactose-Free Infant Formula Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing lactose intolerance among infants.
        2. Rising consumer awareness about lactose intolerance and its effects.
        3. Growing demand for dairy alternatives.
      2. Restraints
        1. Higher production costs compared to conventional infant formulas.
        2. Limited availability of lactose-free infant formula variants.
        3. Regulatory challenges and stringent standards for infant nutrition products.
      3. Opportunities
        1. Expansion in emerging markets with rising disposable incomes.
        2. Technological advancements in manufacturing processes.
        3. Increasing investment in research and development for innovative products.
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Lactose-Free Infant Formula Market, By Product, 2021 - 2031 (USD Million)
      1. Organic
      2. Conventional
    2. Lactose-Free Infant Formula Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Supermarkets & Hypermarkets
      2. Convenience Stores
      3. Online
    3. Lactose-Free Infant Formula Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Nestlé S.A.
      2. Danone S.A.
      3. Abbott Laboratories
      4. Mead Johnson Nutrition Company
      5. Perrigo Company plc
      6. HiPP GmbH & Co. Vertrieb KG
      7. Beingmate Baby & Child Food Co., Ltd.
      8. Ausnutria Dairy Corporation Ltd.
      9. Hain Celestial Group, Inc.
      10. Reckitt Benckiser Group plc
  7. Analyst Views
  8. Future Outlook of the Market